UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective

Current oncology (Toronto), 2023-08, Vol.30 (9), p.8019-8038

2023

Link zum Volltext

Verfügbarkeit prüfen

A Targetable EGFR-Dependent Tumor-Initiating Program in Breast Cancer

Cell reports (Cambridge), 2017-10, Vol.21 (5), p.1140-1149

2017

Link zum Volltext

Verfügbarkeit prüfen

A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in Canada

Current oncology (Toronto), 2023-07, Vol.30 (8), p.7132-7150

2023

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab for advanced anal squamous cell carcinoma (ASCC): Results from the multicohort, phase II KEYNOTE-158 study

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.1-1

2020

Link zum Volltext

Verfügbarkeit prüfen

Survival and Recurrence Patterns after Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) for Locally Advanced Esophagogastric Adenocarcinoma

Annals of surgical oncology, 2015-01, Vol.22 (1), p.324-330

2015

Link zum Volltext

Verfügbarkeit prüfen

Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumors

Communications biology, 2020-06, Vol.3 (1), p.310-310, Article 310

2020

Link zum Volltext

Verfügbarkeit prüfen

Adapting and Evaluating an AI-Based Chatbot Through Patient and Stakeholder Engagement to Provide Information for Different Health Conditions: Master Protocol for an Adaptive Platform Trial (the MARVIN Chatbots Study)

JMIR research protocols, 2024-02, Vol.13, p.e54668-e54668

2024

Link zum Volltext

Verfügbarkeit prüfen

Remote Follow-up of Self-isolating Patients With COVID-19 Using a Patient Portal: Protocol for a Mixed Methods Pilot Study (Opal-COVID Study)

JMIR research protocols, 2022-08, Vol.11 (8), p.e35760-e35760

2022

Link zum Volltext

Verfügbarkeit prüfen

Acceptability of a Patient Portal (Opal) in HIV Clinical Care: A Feasibility Study

Journal of personalized medicine, 2021-02, Vol.11 (2), p.134

2021

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

The lancet oncology, 2018-07, Vol.19 (7), p.940-952

2018

Link zum Volltext

Verfügbarkeit prüfen

The Cardiovascular Risks Associated with Aromatase Inhibitors, Tamoxifen, and GnRH Agonists in Women with Breast Cancer

Current atherosclerosis reports, 2023-04, Vol.25 (4), p.145-154

2023

Link zum Volltext

Verfügbarkeit prüfen

The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer

British journal of cancer, 2017-01, Vol.116 (1), p.103-108

2017

Link zum Volltext

Verfügbarkeit prüfen

Fatal Fast-Growing Renal Cell Carcinoma During Pregnancy

Journal of obstetrics and gynaecology Canada, 2011-03, Vol.33 (3), p.258-261

2011

Link zum Volltext

Verfügbarkeit prüfen

Treatment selection and outcomes of locally advanced esophageal cancer in octo- and nonagenarians: Is a curative intent multimodal approach feasible?

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.333-333

2023

Link zum Volltext

Verfügbarkeit prüfen

AZUR-2, a phase III, open-label, randomized study of perioperative dostarlimab monotherapy vs standard of care in previously untreated patients with T4N0 or stage III dMMR/MSI-H resectable colon cancer

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.TPS240-TPS240

2024

Link zum Volltext

Verfügbarkeit prüfen

Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing

Journal of medical genetics, 2022-08, Vol.59 (8), p.793

2022

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel-Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15-Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer Network

Annals of surgical oncology, 2024-04, Vol.31 (4), p.2461-2469

2024

Link zum Volltext

Verfügbarkeit prüfen

A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2020-03, Vol.20 (2), p.254-264

2020

Link zum Volltext

Verfügbarkeit prüfen

Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study

The lancet. Gastroenterology & hepatology, 2020-03, Vol.5 (3), p.285-294

2020

Link zum Volltext

Verfügbarkeit prüfen

Survival in esophageal cancer with nonregional lymphadenopathy: a propensity score–matched analysis

Journal of gastrointestinal surgery, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel-based triplet neoadjuvant therapy for esophageal adenocarcinoma: A comprehensive analysis of outcomes spanning over a decade

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.332-332

2023

Link zum Volltext

Verfügbarkeit prüfen

Post-docetaxel options for further survival benefit in metastatic castration-resistant prostate cancer: Questions of choice

Canadian Urological Association journal, 2013-02, Vol.7 (1-2 Suppl 1), p.S11-S17

2013

Link zum Volltext

Verfügbarkeit prüfen

Survival and perioperative outcomes of octo- and nonagenarians with resectable esophageal carcinoma

Diseases of the esophagus, 2023-11, Vol.36 (12)

2023

Link zum Volltext

Verfügbarkeit prüfen

A survey of healthcare professionals and oncology patients at the McGill University Health Centre reveals enthusiasm towards establishing a post-mortem rapid tissue donation program

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e23005-e23005

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(48)
Tagungsberichte
(1)

Sprache

Englisch
(49)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Humans
(13)
Female
(11)
Oncology
(11)
Male
(8)
Aged
(7)
Chemotherapy
(7)
Metastasis
(6)
Middle Aged
(6)
Patients
(6)
Adult
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Gastroenterology & Hepatology
(5)
Medicine
(4)
Medicine & Public Health
(4)
Pancreatic Cancer
(4)
Prognosis
(4)
Retrospective Studies
(4)
Surgery
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective

A Targetable EGFR-Dependent Tumor-Initiating Program in Breast Cancer

A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in Canada

Pembrolizumab for advanced anal squamous cell carcinoma (ASCC): Results from the multicohort, phase II KEYNOTE-158 study

Survival and Recurrence Patterns after Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) for Locally Advanced Esophagogastric Adenocarcinoma

Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumors

Adapting and Evaluating an AI-Based Chatbot Through Patient and Stakeholder Engagement to Provide Information for Different Health Conditions: Master Protocol for an Adaptive Platform Trial (the MARVIN Chatbots Study)

Remote Follow-up of Self-isolating Patients With COVID-19 Using a Patient Portal: Protocol for a Mixed Methods Pilot Study (Opal-COVID Study)

Acceptability of a Patient Portal (Opal) in HIV Clinical Care: A Feasibility Study

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

The Cardiovascular Risks Associated with Aromatase Inhibitors, Tamoxifen, and GnRH Agonists in Women with Breast Cancer

The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Fatal Fast-Growing Renal Cell Carcinoma During Pregnancy

Treatment selection and outcomes of locally advanced esophageal cancer in octo- and nonagenarians: Is a curative intent multimodal approach feasible?

AZUR-2, a phase III, open-label, randomized study of perioperative dostarlimab monotherapy vs standard of care in previously untreated patients with T4N0 or stage III dMMR/MSI-H resectable colon cancer

Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing

Docetaxel-Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15-Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer Network

A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer

Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study

Survival in esophageal cancer with nonregional lymphadenopathy: a propensity score–matched analysis

Docetaxel-based triplet neoadjuvant therapy for esophageal adenocarcinoma: A comprehensive analysis of outcomes spanning over a decade

Post-docetaxel options for further survival benefit in metastatic castration-resistant prostate cancer: Questions of choice

Survival and perioperative outcomes of octo- and nonagenarians with resectable esophageal carcinoma

A survey of healthcare professionals and oncology patients at the McGill University Health Centre reveals enthusiasm towards establishing a post-mortem rapid tissue donation program

Suchergebnisse filtern